RUC. Repositorio da Universidade da Coruña
Publicación
Artículo científico (JournalArticle)
Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis
Data availability: The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (https://www.ebi.ac.uk/pride/archive/projects/PXD012879) with the dataset identifier PXD012879 and the project name of MSCs OA SILAC Mass spectrometry imaging, [Abstract] In osteoarthritis (OA), impairment of cartilage regeneration can be related to a defective chondrogenic differentiation of mesenchymal stromal cells (MSCs). Therefore, understanding the proteomic- and metabolomic-associated molecular events during the chondrogenesis of MSCs could provide alternative targets for therapeutic intervention. Here, a SILAC-based proteomic analysis identified 43 proteins related with metabolic pathways whose abundance was significantly altered during the chondrogenesis of OA human bone marrow MSCs (hBMSCs). Then, the level and distribution of metabolites was analyzed in these cells and healthy controls by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), leading to the recognition of characteristic metabolomic profiles at the early stages of differentiation. Finally, integrative pathway analysis showed that UDP-glucuronic acid synthesis and amino sugar metabolism were downregulated in OA hBMSCs during chondrogenesis compared with healthy cells. Alterations in these metabolic pathways may disturb the production of hyaluronic acid (HA) and other relevant cartilage extracellular matrix (ECM) components. This work provides a novel integrative insight into the molecular alterations of osteoarthritic MSCs and potential therapeutic targets for OA drug development through the enhancement of chondrogenesis., This work has been funded by Fondo Investigación Sanitaria-Spain (grant numbers PI14/01707, PI16/02124, PI17/00404, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD12/0009/0018), a part of the National Plan for Scientific Program Development and Technological Innovation 2013–2016, funded by the ISCIII-General Subdirection of Assessment and Promotion of Research - European Regional Development Fund (FEDER) “A way of making Europe.” The Proteomics Unit of GIR belongs to ProteoRed, PRB2- ISCIII (grant number PT17/0019/0014). B.R. is supported by Xunta de Galicia (IN606B-2016/004). The research was partially performed within the M4I research program, financially supported by the Dutch Province of Limburg as part of the “LINK” program, Xunta de Galicia; IN606B-2016/004, https://www.ebi.ac.uk/pride/archive/projects/PXD012879
Proyecto:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 PI14-01707
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 PI16-02124
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 PI17-00404
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 DTS17-00200
,
MSC / Plan Nacional de I+D+i 2004-2007 CB06-01-0040
,
MINECO / Plan Nacional de I+D+i 2008-2011 RD12-0009-0018
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PT17-0019-0014
HANDLE: http://hdl.handle.net/2183/25685
Ver en: http://hdl.handle.net/2183/25685